This report identifies key demand-side trends in the life sciences industry that can help enterprises fine-tune their digital strategies. It also provides an overview of enterprise challenges in this space based on Avasant’s assessment.
Why read this Market Insights?
The life sciences industry is accelerating digital investments in generative AI, advanced analytics, automation, and cybersecurity to enhance efficiency and innovation. Improving R&D is crucial for faster treatment delivery, while advances in genomics drive personalized medicine. Additionally, strengthening manufacturing and supply chains ensures agility and continuity in providing critical therapies. Similarly, optimizing sales and marketing strategies enhances customer engagement and market access. ESG adoption is also growing in the industry due to regulatory pressures, investor expectations, and a commitment to sustainability. To navigate these transformations, life sciences companies collaborate with service providers for digital transformation and technological expertise.
The Life Sciences Digital Services 2025 Market Insights™ aids enterprises in this sector in identifying important market trends and challenges for any digital project they participate in.
Methodology
The industry insights presented in this report are based on our ongoing interactions with enterprise CXOs and other key executives; targeted discussions with service providers, subject matter experts, and Avasant Fellows; analyst insights from primary and secondary research; and lessons learned from consulting engagements.
Table of contents
About the report (Page 3)
Executive summary (Pages 4–7)
-
- Scope of coverage
- Key market drivers and enterprise response
- Avasant recognizes 20 top-tier service providers supporting the digital transformation of life sciences enterprises
Demand-side trends (Pages 8–13)
-
- Life sciences enterprises use Gen AI to shorten drug development timelines by generating molecules, predicting drug-target interactions, optimizing trials, and expediting regulatory submissions
- Life sciences organizations are utilizing genomic data platforms powered by Gen AI to analyze vast datasets, driving biomarker discovery, precision diagnostics, and personalized medicine
- Life sciences organizations are utilizing Industry 4.0, real-time analytics, AI, and advanced supply chain strategies to drive continuous manufacturing, small-batch production for advanced therapies, and greater transparency
- Life sciences organizations are adopting digital-first commercial models, leveraging AI-driven engagement, omnichannel marketing, and predictive analytics to enhance patient-centric strategies, improve adherence, and expand direct-to-consumer access through digital health and telemedicine
Key contacts (Page 14)
Read the Research Byte based on this report. Please refer to Avasant’s Life Sciences Digital Services 2025 RadarView™ for detailed insights on the service providers and supply-side trends.